Bicycle Therapeutics (BCYC) Construction in Progress (2022 - 2023)
Bicycle Therapeutics (BCYC) posted Construction in Progress of $400000.0 for Q2 2023, down 82.61% on a QoQ basis from $2.3 million in Q4 2022.
Bicycle Therapeutics (BCYC) Construction in Progress (2022 - 2023) Analysis & Trends
Bicycle Therapeutics' Construction in Progress history runs 2 years deep, the most recent figure standing at $400000.0 for Q2 2023.
- Quarterly Construction in Progress changed N/A year-over-year to $400000.0 in Q2 2023, while the trailing twelve-month figure through Jun 2023 was $400000.0 (changed N/A YoY) and the FY2022 annual result came in at $2.3 million, changed N/A from the prior year.
- Construction in Progress was $400000.0 for Q2 2023 at Bicycle Therapeutics, down from $2.3 million in the prior quarter.
- Across five years, Construction in Progress topped out at $2.3 million in Q4 2022 and bottomed at $400000.0 in Q2 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Construction in Progress (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 137.45 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Bicycle Therapeutics | 289.88 Mn | 289.88 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2023 | 400,000.00 |
| Dec 31, 2022 | 2.30 Mn |